Publications
Partners
New York - Wall Street stocks dropped on Tuesday on worries about weak first-quarter earnings as Allergan slumped on new US tax rules that threaten the drugmaker's takeover by Pfizer.
The Dow Jones Industrial Average fell 133.68 points (0.75%) to 17 603.32.
The broad-based S&P 500 shed 20.96 (1.01%) to 2 045.17, while the tech-rich Nasdaq Composite Index dropped 47.86 (0.98%) to 4 843.93.
Companies in the S&P 500 are expected to see a 4.2% drop in earnings for the first-quarter, according to S&P Capital IQ.
"Investors are in a wait-and-see mode as we prepare for the earnings season to evaluate whether the recovery we've seen from the February lows should be justified or whether stocks have gotten ahead of themselves," said David Levy, portfolio manager at Republic Wealth Advisors.
Dublin-based Allergan plummeted 14.8% as the US Treasury announced new rules to discourage mergers between US and foreign businesses designed to sharply lower the US company's tax bill. Dow member Pfizer added 2.1%.
Baker Hughes tumbled 5.1% on reports that the US Justice Department will sue to block its takeover by fellow oil-services giant Halliburton on antitrust grounds. Halliburton advanced 1.2%.
Dow member Disney lost 1.7% after the surprise resignation of chief operating officer Thomas Staggs, who had been the leading candidate to replace chief executive Bob Iger. Topeka Capital Markets called the news "truly stunning" and predicted Iger's contract would be extended to assuage investors.
Valeant Pharmaceuticals International vaulted 10% after announcing that it completed an accounting review and would not need to make further revisions to its earnings.
Walgreens Boots Alliance fell 3.4% after the pharmacy chain reported second-quarter sales of $30.2bn, under the $30.7bn projected by analysts.
Banking shares were in retreat, with Bank of America shedding 2.4%, Citigroup 1.3% and Wells Fargo 2%.
